CXCR2 and neoplasm: In contrast, a significantly stronger T-cell presence was observed in the tumors of two mice treated with A20-28z CXCR2 CAR T-cells (the third mouse had no macroscopically evident tumor at the experimental endpoint), including infiltration into the tumor core (Figure 6D,F).